Getting your ADCs to the clinic: Considerations for early stage development
Date: | 02-Dec-13 to 02-Dec-13 |
Location: | Holiday Inn Bloomsbury / London / United Kingdom |
Category: | Healthcare & Pharmaceuticals Science Conferences & Trade Fairs |
The development of existing or novel monoclonal antibodies as drug-conjugates to increase the targeted clinical effect of these proteins has rapidly increased in recent years.
SMi's masterclass hosted by PAREXEL International will discuss ADCs which are being tested in the clinic in a range of oncology indications. In the absence of specific guidance on the development of ADCs, this workshop aims to help participants understand the CMC issues during the development, with a particular focus on the assessment and control of the quality of such products.
Benefits of Attending
• Identify key parameters for non-clinical studies to support a Phase 1 clinical trial
• Consider the factors that influence the choice of conjugate and linker types
• Learn how to create an early phase product development plan that meets regulatory expectations
• Network with and learn from senior industry representatives
Contact Fateja Begum Tel: +44 (0) 20 7827 6184 Email: fbegum@smi-online.co.uk
Book online: www.smi-online.co.uk/2013adc-development1.asp
SMi's masterclass hosted by PAREXEL International will discuss ADCs which are being tested in the clinic in a range of oncology indications. In the absence of specific guidance on the development of ADCs, this workshop aims to help participants understand the CMC issues during the development, with a particular focus on the assessment and control of the quality of such products.
Benefits of Attending
• Identify key parameters for non-clinical studies to support a Phase 1 clinical trial
• Consider the factors that influence the choice of conjugate and linker types
• Learn how to create an early phase product development plan that meets regulatory expectations
• Network with and learn from senior industry representatives
Contact Fateja Begum Tel: +44 (0) 20 7827 6184 Email: fbegum@smi-online.co.uk
Book online: www.smi-online.co.uk/2013adc-development1.asp
Visitors
• Drug Discovery
• Biologics
• Biologics generation
• Antibody research
• Antibody conjugate development
• Antibody conjugate discovery
• Biomolecular Research
• Genomics Research
• Antibody Engineering
• Protein Sciences
• Protein Technologies
• Bioanalytics
• Cell Assays
• Molecular Cell Biology
• Drug Discovery Pharmacology
• Regulatory Affairs
• CMC
• Biotherapeutics
• In Vitro Platforms
• Antibody and Vaccine leads
• Monoclonal Antibodies
• Oncology
• Molecular & Translational
• Biologics
• Biologics generation
• Antibody research
• Antibody conjugate development
• Antibody conjugate discovery
• Biomolecular Research
• Genomics Research
• Antibody Engineering
• Protein Sciences
• Protein Technologies
• Bioanalytics
• Cell Assays
• Molecular Cell Biology
• Drug Discovery Pharmacology
• Regulatory Affairs
• CMC
• Biotherapeutics
• In Vitro Platforms
• Antibody and Vaccine leads
• Monoclonal Antibodies
• Oncology
• Molecular & Translational
Exhibitors
• Drug Discovery
• Biologics
• Biologics generation
• Antibody research
• Antibody conjugate development
• Antibody conjugate discovery
• Biomolecular Research
• Genomics Research
• Antibody Engineering
• Protein Sciences
• Protein Technologies
• Bioanalytics
• Cell Assays
• Molecular Cell Biology
• Drug Discovery Pharmacology
• Regulatory Affairs
• CMC
• Biotherapeutics
• In Vitro Platforms
• Antibody and Vaccine leads
• Monoclonal Antibodies
• Oncology
• Molecular & Translational
• Biologics
• Biologics generation
• Antibody research
• Antibody conjugate development
• Antibody conjugate discovery
• Biomolecular Research
• Genomics Research
• Antibody Engineering
• Protein Sciences
• Protein Technologies
• Bioanalytics
• Cell Assays
• Molecular Cell Biology
• Drug Discovery Pharmacology
• Regulatory Affairs
• CMC
• Biotherapeutics
• In Vitro Platforms
• Antibody and Vaccine leads
• Monoclonal Antibodies
• Oncology
• Molecular & Translational
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- CNES News Today
- Canadian Space Agency News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- JAXA News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- NASA News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- Research Reports News Today
- SARS News Today
- Science News Today
- Wellness News Today